You are here
Funding
New Funding Opportunities
| Notice | Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R21 Clinical Trial Optional) |
|---|---|
| Notice Number | PAR-25-115 |
| Post Date | October 17, 2024 |
| Expiration Date | November 17, 2025 |
| Notice | Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R01 Clinical Trial Optional) |
|---|---|
| Notice Number | PAR-25-116 |
| Post Date | October 17, 2024 |
| Expiration Date | November 6, 2025 |
Past Funding Opportunities
|
Notice |
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRCs) (U54 Clinical Trial Optional) |
|---|---|
| Notice Number | RFA-NS-24-022 |
|
Notice |
Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R01 Clinical Trial Optional) |
|---|---|
| Notice Number | RFA-NS-23-021 |
|
Notice |
Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R21 Clinical Trial Optional) |
|---|---|
| Notice Number | RFA-NS-23-022 |
|
Notice |
Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R01 Clinical Trials Not Allowed) |
|---|---|
| Notice Number | PAR-20-165 |
|
Notice |
Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R21 Clinical Trial Not Allowed) |
|---|---|
| Notice Number | PAR-20-168 |
|
Notice |
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRCs) (U54 Basic Experimental Studies Involving Humans Allowed) |
|---|---|
| Notice Number | RFA-NS-22-019 |
| Notice | Data Management and Coordinating Center (DMCC) for the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRC) (U24 Basic Experimental Studies with Humans Required) |
|---|---|
| Notice Number | RFA-NS-22-020 |
| Notice | Clinical Validation of a Candidate Biomarker for Neurological Disease (U01 Clinical Trial Optional) |
|---|---|
| Notice Number | PAR-18-664 |
| Notice | Analytical Validation of a Candidate Biomarker for Neurological Disease (U01 Clinical Trial Optional) |
|---|---|
| Notice Number | PAR-18-550 |
| Notice | Analytical Validation of a Candidate Biomarker for Neurological Disease (U44 Clinical Trial Optional) |
|---|---|
| Notice Number | PAR-18-549 |
| Notice | Clinical Validation of a Candidate Biomarker for Neurological Disease (U44 Clinical Trial Optional) |
|---|---|
| Notice Number | PAR-18-548 |
This page last reviewed on January 21, 2025